UM: Targeting CARM1 Inhibits AML and Spares Normal Cells

UM: Targeting CARM1 Inhibits AML and Spares Normal Cells

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that inhibiting the enzyme CARM1 (also called PRMT4) dramatically slows acute myeloid leukemia (AML) progression but does not affect normal blood production.

Full Story

Related posts

FIU: Researchers investigate sleep’s role in emotional experiences for teens

Researchers at the FIU Center for Children and Families are trying to uncover the role…

FAMU-FSU College of Engineering, Air Force Research Laboratory Celebrate New Partnership

The FAMU-FSU College of Engineering and researchers and engineers from Eglin Air Force Base celebrated…

USF Forum on Aging & Technology Brings Researchers and Industry Together

TAMPA – In the not too distant future, the homes of elderly people might be…